Bath Savings Trust Co Sells 61 Shares of Intuitive Surgical, Inc. $ISRG

Bath Savings Trust Co lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,808 shares of the medical equipment provider’s stock after selling 61 shares during the period. Bath Savings Trust Co’s holdings in Intuitive Surgical were worth $6,960,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the stock. AlphaCore Capital LLC lifted its stake in shares of Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock valued at $235,000 after buying an additional 18 shares during the period. Aaron Wealth Advisors LLC lifted its stake in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares during the period. Crown Wealth Group LLC lifted its stake in Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after purchasing an additional 20 shares during the period. FSM Wealth Advisors LLC lifted its stake in Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after purchasing an additional 20 shares during the period. Finally, CFO4Life Group LLC lifted its stake in Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 20 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $433.66 on Thursday. The firm has a fifty day moving average of $479.91 and a two-hundred day moving average of $505.85. The stock has a market capitalization of $155.46 billion, a price-to-earnings ratio of 60.48, a PEG ratio of 4.56 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.78 EPS. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares of the company’s stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock worth $21,716,492. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Piper Sandler restated an “overweight” rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Evercore ISI raised their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Citigroup restated a “buy” rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Finally, UBS Group raised their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.